Thermo Fisher Scientific has launched Applied Biosystems TrueMark STI Select Panel, a polymerase chain reaction (PCR) research use only test designed to detect Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Mycoplasma genitalium in one test, as well as RNase P, included as a human internal control.

This panel will enable researchers to detect these sexually transmitted infectious microorganisms faster and with higher accuracy, and help enable understanding of testing regimens and potential treatments in the future.

The test can analyze samples collected from vaginal or genital swabs in one reaction well and is optimized for use with QuantStudio real-time PCR instruments. These samples can also be prepared using workflows that currently exist in most labs that use the Applied Biosystems MagMAX Viral/Pathogen kits automated on a KingFisher Purification System instrument and mixed with the Applied Biosystems multiplex master mix onto a 96-well or 384-well plate.

The high specificity and sensitivity panel can be used by researchers to study outbreaks of STIs at a much faster rate, providing results within four hours, whereas other PCR tests for just one target can take over three hours each.

The TrueMark STI Select Panel is sold as a combo kit, which includes the STI panel assay and master mix; positive controls are also included for added accuracy and efficiency.

For more information on Thermo Fisher’s TrueMark STI Panel, please visit: www.thermofisher.com/truemarkstiselectpanel

For Research Use Only. Not for use in diagnostic procedures.